KCNH2 and pancreatic insulinoma: The effects of E4031 on cell viability of the insulinoma cell line suggest that hERG1 could be exploited as a therapeutic target also in NETs, at least in early stages pNETS, which are well modelled by the INS1E cells and where hERG1 is highly expressed (see Table 5).